Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome.
N
N
Sekine
T
T
Motokura
T
T
Oki
Y
Y
Umeda
N
N
Sasaki
M
M
Hayashi
H
H
Sato
T
T
Fujita
T
T
Kaneko
Y
Y
Asano
K
K
Kikuchi
D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D000743:Anemia, Hemolytic / Q000150:complications* / Q000209:etiology; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000209:etiology; D002096:C-Peptide / Q000097:blood; D002220:Carbamazepine / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000209:etiology / Q000378:metabolism*; D016883:Diabetic Ketoacidosis / Q000209:etiology* / Q000378:metabolism; D003875:Drug Eruptions / Q000150:complications* / Q000209:etiology; D005260:Female; D006566:Herpesviridae Infections / Q000150:complications*; D015654:Herpesvirus 6, Human; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D013577:Syndrome
D018712:Analgesics, Non-Narcotic; D002096:C-Peptide; D007328:Insulin; D002220:Carbamazepine